Meta Pixel

News and Announcements

Sniip’s mobile application takes a huge step forward partnering with American Express

  • Published January 10, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Sniip, a mobile-based payment solution, has taken their application further into the market, partnering with one of the biggest financial services providers – American Express.

This step has undeniably made the application more accessible to a larger group of people, with added benefits.

Sniip Founder Damien Vasta said:

“Our partnership with American Express represents a huge step forward for Sniip. Aussies can now pay any household bill offering BPAY, any way they want, from one app on their mobile. Most importantly, American Express users can get the benefit of using their card for everyday payments that haven’t been available until now.”

Register Interest

About Sniip Ltd

Sniip is a mobile payments application and it is designed to be the new way that Australians pay and manage bills. It is the easiest and fastest way to pay and manage bills on a mobile.

Sniip is bank and card agnostic, uniquely built around the consumer to allow them control how they pay and manage their bills – irrespective of how a biller or bank currently dictates how this is done.

Sniip allows a consumer to pay their bills using any debit or credit card (including AMEX) whilst providing the tools to make sure you never miss a due date again.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now